FDA
approval
· 2023-12-08
FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
Summary
FDA issued a supplemental approval for fentanyl transdermal product submitted by SpecGx LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FENTANYL TRANSDERMAL (FENTANYL TRANSDERMAL)